The virtual house call
A 21st-century innovation in the care of patients with Parkinson disease
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
As the debate on health care reform rages in the United States, one thing is exceedingly clear: chronic disease accounts for a growing majority of American health care costs.1 Many chronic diseases, particularly Parkinson disease (PD), can benefit from specialty care. Patients with PD show more improvements in motor symptoms and less frequently receive inappropriate medications when treated by a specialist.2,3 However, reduced mobility due to PD, combined with the physical distance to the specialist's office, poses substantial travel burdens and may limit access to care. Telemedicine, utilizing video and audio conferencing technology to connect patients and clinicians, can mitigate this problem. However, Centers for Medicare Services (CMS) currently only covers telemedicine encounters under specific criteria: the patient lives in a rural area seen in a covered entity by a consulting physician licensed in the state in which the patient resides.4 Even if the rural designation were removed, requiring travel to a center that offers telemedicine consultation may preclude many patients from using this approach. Modern Internet-based technologies, utilizing Health Information Portability and Accountability Act–compliant software, allow physicians to perform virtual house calls, thus minimizing travel. This has the potential to increase access to care for patients with a debilitating disease dramatically. While remote examiners cannot perform rigidity and balance testing, they can perform a modified motor examination of similar clinical utility without these components.5
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the editorial.
See page 1152
- © 2017 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Disputes & Debates: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.